Olsson, R F <br/><br/>
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.  [electronic resource] 

 -  Leukemia  Aug 2015 
 - 1754-62 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>1476-5551 
<br/><br/><label>Standard No.: </label>10.1038/leu.2015.75  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Child<br/>Child, Preschool<br/>Female<br/>Follow-Up Studies<br/>Graft Survival<br/>Graft vs Host Disease--drug therapy<br/>Hematologic Neoplasms--complications<br/>Hematopoietic Stem Cell Transplantation--adverse effects<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Middle Aged<br/>Myeloablative Agonists--adverse effects<br/>Neoplasm Staging<br/>Primary Graft Dysfunction--drug therapy<br/>Prognosis<br/>Retrospective Studies<br/>Survival Rate<br/>Transplantation Conditioning--adverse effects<br/>Transplantation, Homologous<br/>Young Adult